Infusion & Drug Delivery Devices · Biotechnology
Halozyme: Risk & public record
Halozyme: 59 research papers in five years.
Data updated Nov 22, 2026 · Back to the company report
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
Halozyme: 59 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
59papers in five years
11kcitations
Proteoglycans and glycosaminoglycans research
Biochemistry, Genetics and Molecular Biology
157 papers
Pancreatic and Hepatic Oncology Research
Medicine
80 papers
Hydrogels: synthesis, properties, applications
Materials Science
49 papers
Intramuscular injections and effects
Medicine
36 papers
Monoclonal and Polyclonal Antibodies Research
Immunology and Microbiology
30 papers
Works most with: Novartis (Switzerland), City Of Hope National Medical Center, City of Hope, Beckman Research Institute, The Ohio State University, Monash University
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
